INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 422m ago
House PTR22m ago
SEC 13F21m ago
Robinhood Chain21m ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02FWFogarty Patrick W0B / 206S206 trades$1.10M
  3. 03SPSaba Capital Management, L.P.65B / 19S · 11 late84 trades$21.64M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09SISarowitz Steven I2B / 34S36 trades$22.46M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 179 insiders$893K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

72,770 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
RK
Robinson KatrinaDirector
MCBMetropolitan Bank Holding Corp.
Grant or award
A—
2,500 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

21
VM
VanHimbergen Robert MEVP and CFO
ELANElanco Animal Health Inc
Grant or award
A$190
8 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

21
AV
Abate VictorChief Executive Officer, Wind
GEVGE Vernova Inc.
Grant or award
A—
1,163 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

21
JM
Jordt Raymond MChief Business Officer
ALTAltimmune, Inc.
Option exercise
M—
14.6K sh
Jan 25, 2026Jan 27, 2026
traded Jan 25, 2026
+2dSEC Form 4

Evidence

21
RM
Ramani MohitChief Risk Officer
KEYKEYCORP /NEW/
Option exercise
M—
61.5K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

21
RS
Roberts M ScotChief Scientific Officer
ALTAltimmune, Inc.
Option exercise
M—
14.6K sh
Jan 25, 2026Jan 27, 2026
traded Jan 25, 2026
+2dSEC Form 4

Evidence

20
HK
Hogan Catherine KiernanChief Operating Officer
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$283
1 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

20
WF
Walsh John FCEO-The Americas
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$3,360
12 sh
Jan 27, 2026Jan 27, 2026
traded Jan 27, 2026
+0dSEC Form 4

Evidence

20
CL
Clifford Katherine LeeChief Leadership & HR Officer
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$145K
514 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

20
HK
Hogan Catherine KiernanChief Operating Officer
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$30K
107 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

20
HK
Hogan Catherine KiernanChief Operating Officer
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$17K
62 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

19
HE
Horn Daniel E.Chief Commercial Officer
AMRAlpha Metallurgical Resources, Inc.
Tax withholding
F$370K
1,600 sh
Jan 25, 2026Jan 27, 2026
traded Jan 25, 2026
+2dSEC Form 4

Evidence

18
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$244K
8,135 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

18
TM
Toni Alberto Michele MariaCFO
GESGUESS INC
Other acquisition or disposition
J$557K
33.3K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

18
WD
Weinswig DeborahDirector
GESGUESS INC
Other acquisition or disposition
J$451K
26.9K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

18
BF
Benarouche FabriceSVP Finance and IR, CAO
GESGUESS INC
Other acquisition or disposition
J$450K
26.9K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

17
WE
Whitehead Jason E.President & COO
AMRAlpha Metallurgical Resources, Inc.
Grant or award
A—
4,028 sh
Jan 25, 2026Jan 27, 2026
traded Jan 25, 2026
+2dSEC Form 4

Evidence

17
DR
Davoli RodrigoSVP & GM, North America
SLVMSylvamo Corp
Grant or award
A$10K
204 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

17
MA
Marinof AlexisCEO, Europe
WTWisdomTree, Inc.
Grant or award
A—
44.3K sh
Jan 25, 2026Jan 27, 2026
traded Jan 25, 2026
+2dSEC Form 4

Evidence

17
LS
Lawson ShawnSVP, General Manager Europe
SLVMSylvamo Corp
Grant or award
A$6,671
131 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

17
MT
Munsey Joshua ToddChief Financial Officer
AMRAlpha Metallurgical Resources, Inc.
Grant or award
A—
2,352 sh
Jan 25, 2026Jan 27, 2026
traded Jan 25, 2026
+2dSEC Form 4

Evidence

17
HJ
Hoff Brian JosephChief Financial Officer
UMACUnusual Machines, Inc.
Grant or award
A—
110.0K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

17
LA
Lee AdriannePresident & CFO
BBBYBED BATH & BEYOND, INC.
Option exercise
M$2.1
21.0K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

17
KJ
Kuffner JamesCHIEF TECHNOLOGY OFFICER
SYMSymbotic Inc.
Option exercise
M—
191.7K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

17
EA
Eidson Charles AndrewDirector, Chief Executive Officer
AMRAlpha Metallurgical Resources, Inc.
Grant or award
A—
6,521 sh
Jan 25, 2026Jan 27, 2026
traded Jan 25, 2026
+2dSEC Form 4

Evidence

17
CP
Coleman Denis P.Chief Financial Officer
GSGOLDMAN SACHS GROUP INC
Option exercise
M—
5,249 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

17
PC
Pamula ChayaDirector
MCBMetropolitan Bank Holding Corp.
Grant or award
A—
2,500 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

17
FG
Freve Maria GSee Remarks
SYMSymbotic Inc.
Option exercise
M—
13.8K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

17
JM
Jordt Raymond MChief Business Officer
ALTAltimmune, Inc.
Option exercise
M—
14.6K sh
Jan 25, 2026Jan 27, 2026
traded Jan 25, 2026
+2dSEC Form 4

Evidence

17
DP
Devlin Donald P.SVP Chief Financial Officer
SLVMSylvamo Corp
Grant or award
A$8,523
167 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

17
FG
Freve Maria GSee Remarks
SYMSymbotic Inc.
Option exercise
M—
1,144 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

17
LA
Lee AdriannePresident & CFO
BBBYBED BATH & BEYOND, INC.
Option exercise
M—
21.0K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

17
FG
Freve Maria GSee Remarks
SYMSymbotic Inc.
Option exercise
M—
13.8K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

17
KJ
Kuffner JamesCHIEF TECHNOLOGY OFFICER
SYMSymbotic Inc.
Option exercise
M—
191.7K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

16
WJ
Wolf George J JrDirector
MCBMetropolitan Bank Holding Corp.
Gift
G—
1,720 sh
Jan 27, 2026Jan 27, 2026
traded Jan 27, 2026
+0dSEC Form 4

Evidence

15
LN
Lewis Christopher N.Director
GESGUESS INC
Other acquisition or disposition
J$242K
14.4K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

15
SJ
Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER
LTHLife Time Group Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$360K
12.1K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

15
CA
Caldwell Christopher ADirector, President and CEO
CNXCConcentrix Corp
Tax withholding
F$437K
10.1K sh
Jan 24, 2026Jan 27, 2026
traded Jan 24, 2026
+3dSEC Form 4

Evidence

15
WD
Weinswig DeborahDirector
GESGUESS INC
Other acquisition or disposition
J$242K
14.4K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

15
ME
Michael ElsaDirector
GESGUESS INC
Other acquisition or disposition
J$242K
14.4K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

Page 1425 of 1820
← PrevNext →